Literature DB >> 22488716

Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results.

Wei Guan1, Jian Bai, Jihong Liu, Shaogang Wang, Qianyuan Zhuang, Zhangqun Ye, Zhiquan Hu.   

Abstract

BACKGROUND AND OBJECTIVES: Prospective randomized comparison of intermediate-term outcomes of patients with small renal tumors who were treated with partial nephrectomy (PN) or microwave ablation.
METHODS: Of 102 selected patients with solitary small renal tumors who had prospectively completed at least 2 years of follow-up since December 2004, randomizedly, 54 had either open (19) or laparoscopic (35) PN and 48 had laparoscopic (28) or open (20) microwave ablation. Patient and tumor characteristics, surgical data, complications, histologic and oncologic data, and functional data of the two approaches were compared.
RESULTS: Patients in microwave ablation group and PN group matched for age, sex, American Society of Anesthesiologists score, body mass index, and tumor size and were respectively followed for median 32 and 36 months. Surgical and hospitalization times were comparable in both groups. Estimated blood loss, complication rates, and decline of postoperative renal function were significantly less in the microwave ablation group (P = 0.0002, P = 0.0187, and P = 0.0092, respectively). The decrease in estimated glomerular filtration rate at the last available follow-up was similar in both groups (P = 1.0000). There were no disease-specific deaths. Kaplan-Meier estimates of overall local recurrence-free survival at 3 years were 91.3% for microwave ablation and 96.0% for PN (P = 0.5414); the respective numbers for renal cell carcinomas were 90.4 and 96.6% (P = 0.4650).
CONCLUSIONS: Microwave ablation can be also safely and efficiently done for patients with small renal tumors. This intermediate analysis showed that microwave ablation provides favorable results compared to PN. However, longer term data are still needed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22488716     DOI: 10.1002/jso.23071

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  27 in total

Review 1.  Contemporary Status of Percutaneous Ablation for the Small Renal Mass.

Authors:  Benjamin J Shin; Jeffrey Forris Beecham Chick; S William Stavropoulos
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

2.  CT imaging during microwave ablation: analysis of spatial and temporal tissue contraction.

Authors:  Dong Liu; Christopher L Brace
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

3.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

4.  Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.

Authors:  Marki E Klapperich; E Jason Abel; Timothy J Ziemlewicz; Sara Best; Meghan G Lubner; Stephen Y Nakada; J Louis Hinshaw; Christopher L Brace; Fred T Lee; Shane A Wells
Journal:  Radiology       Date:  2017-01-11       Impact factor: 11.105

Review 5.  Renal ablation update.

Authors:  Vishal Khiatani; Robert G Dixon
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

6.  Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.

Authors:  Adam D Talenfeld; Renee L Gennarelli; Elena B Elkin; Coral L Atoria; Jeremy C Durack; William C Huang; Sharon W Kwan
Journal:  Ann Intern Med       Date:  2018-06-26       Impact factor: 25.391

Review 7.  Radiofrequency Ablation, Where It Stands in Interventional Radiology Today.

Authors:  Vipulkumar Patel; Charles A Ritchie; Carlos Padula; J Mark McKinney
Journal:  Semin Intervent Radiol       Date:  2019-12-02       Impact factor: 1.513

8.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Authors:  Muneeb Ahmed; Luigi Solbiati; Christopher L Brace; David J Breen; Matthew R Callstrom; J William Charboneau; Min-Hua Chen; Byung Ihn Choi; Thierry de Baère; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; David Gianfelice; Alice R Gillams; Fred T Lee; Edward Leen; Riccardo Lencioni; Peter J Littrup; Tito Livraghi; David S Lu; John P McGahan; Maria Franca Meloni; Boris Nikolic; Philippe L Pereira; Ping Liang; Hyunchul Rhim; Steven C Rose; Riad Salem; Constantinos T Sofocleous; Stephen B Solomon; Michael C Soulen; Masatoshi Tanaka; Thomas J Vogl; Bradford J Wood; S Nahum Goldberg
Journal:  J Vasc Interv Radiol       Date:  2014-10-23       Impact factor: 3.464

Review 9.  Contemporary minimally invasive treatment options for renal angiomyolipomas.

Authors:  Sri Sivalingam; Stephen Y Nakada
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

Review 10.  Ablative therapies for small renal tumours.

Authors:  Arturo Castro; Lawrence C Jenkins; Nelson Salas; Gideon Lorber; Raymond J Leveillee
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.